Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Example Immunization/protocol (XML)

Raw XML (canonical form + also see XML Format Specification)

Jump past Narrative

Example where the provider indicates the protocol being followed (id = "protocol")

<?xml version="1.0" encoding="UTF-8"?>
<Immunization xmlns="http://hl7.org/fhir"><id value="protocol"/><text ><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p ><b >Generated Narrative: Immunization</b><a name="protocol"></a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border:
 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Immunization &quot;protocol&quot; </p></div><p ><b >identifier</b>: id: urn:oid:1.3.6.1.4.1.21367.2005年3月7日.1234</p><p ><b >status</b>: completed</p><p ><b >vaccineCode</b>: Twinrix (HepA/HepB) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-CVX.html">Vaccine Administered Code Set (CVX)</a>#104)</span></p><h3 >Manufacturers</h3><table class="grid"><tr ><td >-</td><td ><b >Reference</b></td></tr><tr ><td >*</td><td ><a href="organization-example.html">Organization/hl7</a> &quot;Health Level Seven International&quot;</td></tr></table><p ><b >lotNumber</b>: PT123F</p><p ><b >expirationDate</b>: 2018年12月15日</p><p ><b >patient</b>: <a href="patient-example.html">Patient/example</a> &quot;Peter CHALMERS&quot;</p><p ><b >encounter</b>: <a href="encounter-example.html">Encounter/example</a></p><p ><b >occurrence</b>: 2018年06月18日</p><p ><b >primarySource</b>: true</p><p ><b >location</b>: <a href="location-example.html">Location/1</a> &quot;South Wing, second floor&quot;</p><p ><b >site</b>: left arm <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v3-ActSite.html">ActSite</a>#LA)</span></p><p ><b >route</b>: Injection, intramuscular <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v3-RouteOfAdministration.html">RouteOfAdministration</a>#IM)</span></p><p ><b >doseQuantity</b>: 5 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM code mg = 'mg')</span></p><blockquote ><p ><b >performer</b></p><p ><b >function</b>: Ordering Provider <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v2-0443.html">providerRole</a>#OP)</span></p><p ><b >actor</b>: <a href="practitioner-example.html">Practitioner/example</a> &quot;Adam CAREFUL&quot;</p></blockquote><blockquote ><p ><b >performer</b></p><p ><b >function</b>: Administering Provider <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v2-0443.html">providerRole</a>#AP)</span></p><p ><b >actor</b>: <a href="practitioner-example.html">Practitioner/example</a> &quot;Adam CAREFUL&quot;</p></blockquote><p ><b >isSubpotent</b>: false</p><h3 >ProgramEligibilities</h3><table class="grid"><tr ><td >-</td><td ><b >Program</b></td><td ><b >ProgramStatus</b></td></tr><tr ><td >*</td><td >VFC <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td><td >Not Eligible <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-immunization-program-eligibility.html">Immunization Program Eligibility</a>#ineligible)</span></td></tr></table><p ><b >fundingSource</b>: Private <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-immunization-funding-source.html">Immunization Funding Source</a>#private)</span></p><blockquote ><p ><b >protocolApplied</b></p><p ><b >series</b>: 2-dose</p><p ><b >targetDisease</b>: Viral hepatitis, type A <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#40468003)</span></p><p ><b >doseNumber</b>: 1</p></blockquote><blockquote ><p ><b >protocolApplied</b></p><p ><b >series</b>: 3-dose</p><p ><b >targetDisease</b>: Type B viral hepatitis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#66071002)</span></p><p ><b >doseNumber</b>: 2</p><p ><b >seriesDoses</b>: 3</p></blockquote></div></text><identifier ><system value="urn:ietf:rfc:3986"/><value value="urn:oid:1.3.6.1.4.1.21367.2005年3月7日.1234"/></identifier><status value="completed"/><vaccineCode ><coding ><system value="http://hl7.org/fhir/sid/cvx"/><code value="104"/></coding><text value="Twinrix (HepA/HepB)"/></vaccineCode><manufacturer ><reference ><reference value="Organization/hl7 "/></reference></manufacturer><lotNumber value="PT123F"/><expirationDate value="2018年12月15日"/><patient ><reference value="Patient/example "/></patient><encounter ><reference value="Encounter/example "/></encounter><occurrenceDateTime value="2018年06月18日"/><primarySource value="true"/><location ><reference value="Location/1 "/></location><site ><coding ><system value="http://terminology.hl7.org/CodeSystem/v3-ActSite"/><code value="LA"/><display value="left arm"/></coding></site><route ><coding ><system value="http://terminology.hl7.org/CodeSystem/v3-RouteOfAdministration"/><code value="IM"/><display value="Injection, intramuscular"/></coding></route><doseQuantity ><valuevalue="5"/><systemvalue="http://unitsofmeasure.org"/><codevalue="mg"/></doseQuantity><performer ><function ><coding ><system value="http://terminology.hl7.org/CodeSystem/v2-0443"/><code value="OP"/></coding></function><actor ><reference value="Practitioner/example "/></actor></performer><performer ><function ><coding ><system value="http://terminology.hl7.org/CodeSystem/v2-0443"/><code value="AP"/></coding></function><actor ><reference value="Practitioner/example "/></actor></performer><isSubpotent value="false"/><programEligibility ><program ><text value="VFC"/></program><programStatus ><coding ><system value="http://terminology.hl7.org/CodeSystem/immunization-program-eligibility"/><code value="ineligible"/></coding></programStatus></programEligibility><fundingSource ><coding ><system value="http://terminology.hl7.org/CodeSystem/immunization-funding-source"/><code value="private"/></coding></fundingSource><protocolApplied ><series value="2-dose"/><targetDisease ><coding ><system value="http://snomed.info/sct"/><code value="40468003"/></coding></targetDisease><doseNumber value="1"/></protocolApplied><protocolApplied ><series value="3-dose"/><targetDisease ><coding ><system value="http://snomed.info/sct"/><code value="66071002"/></coding></targetDisease><doseNumber value="2"/><seriesDoses value="3"/></protocolApplied></Immunization>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.

AltStyle によって変換されたページ (->オリジナル) /